P T 38:446452 Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW (2011) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
thetaiotaomicron bacterial mixture liquid
In the U.S., the list price of these medications can range from $1,000 to $1,500 per month
These agents mimic GLP-1, an endogenous incretin hormone released in response to eating
[5] Observational studies provide additional context but face methodological challenges: patients prescribed GLP-1 receptor agonists typically have more advanced metabolic disease, higher body mass index, and greater baseline pancreatitis risk than comparison groups
Alternative Names: CJC-1295: Modified GHRH analog, CJC-1295 no DAC, Mod GRF 1-29